skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration
  • Close Icon

医療機器市場をリアルタイム分析

Meddevicetracker | Pharma intelligence

Meddevicetracker(メッドデバイストラッカー)を使用することで、競争の激しい医療機器市場での優位性を維持できます。医療機器、診断、高度な配信システムに関して競合製品の評価、重要なイベントの追跡、より的確な情報に基づく意思決定が可能になります。

  • 医療機器市場の競合状況を疾患や機器の種類から把握
  • 研究開発や臨床試験の履歴
  • 医薬品と医療機器または医薬品と診断の組み合わせ
  • 製品、イベントでの検索機能
  • 市場調査レポート、売上予測、メーカーシェアへのアクセス

 

Meddevicetrackerを活用することで以下のことが可能です:

競合分析
自社の開発候補品と競合する開発中の医療機器は?医薬品の投与方法に関して、競合企業の動向を把握したい。

臨床試験
対象領域の臨床試験の情報や進捗を把握する

開発履歴
製品別にこれまでの開発経緯を時系列で追うことができ、今後の動向を推測できます。

検索機能
イベントや今後のマイルストーン、対象となる医療機器を把握しモニタリング

市場分析
医療機器の市場トレンドを理解し、成長が見込めるマーケットを探る。医療機器の市場性を評価したい。また、各企業の売上やマーケットシェアに関するレポートも入手できます。

 

Meddevicetrackerの対象範囲:

  • 心血管系
  • コンパニオン診断
  • 避妊、不妊
  • 糖尿病、肥満
  • ドラッグデリバリー
  • 塞栓性脳卒中予防
  • 止血
  • 腫瘍学
  • 整形外科
  • 痛み
  • 静脈血栓塞栓症
  • 創傷治癒

このサービスの特徴

無料の最新記事&レポート

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker Q3 2019 Outlook Report Extract

    29 Jul 2019

    In this report, we cover catalysts from 27 drugs, devices and diagnostics expected to occur in Q3 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided. These data points were provided using a combination of Pharmapremia, Informa’s drug development benchmarking product utilizing Biomedtracker’s LOA data to assist in informed decisions about drug pipeline prioritization, partnerships, and acquisitions, and drug approval data from Biomedtracker.   

    Topic drug-development-landscape drug-review research strategy

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    2019 Q3 Outlook Webinar

    By Hardik Patel 15 Jul 2019

    Informa Pharma Intelligence presents an essential, free session during which industry analysts present their data-driven views about what to expect during the third quarter of 2019. 

    Topic immuno-oncology infectious-diseases

  • Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...

    When Part of the Picture Isn't Enough

    05 Jul 2019

    Staying on top of what’s going in the competitive Medtech market and getting a complete view of the competitive landscape and current market trends is critical to your business. Often, this essential information is fragmented and difficult to find, and gathering and synthesizing it is tedious and time consuming. Now, Biomedtracker puts this critical information at your fingertips, saving you time and effort. The new “Associated Products” section on relevant Biomedtracker Drug Profile pages shows you the full competitive landscape – including drugs, devices, and diagnostics – with a single search.

    Topic business-strategies medtech

  • Datamonitor Healthcare: 医療用医薬品の市場調査レポート, Biomedtracker: 開発中医...

    Q1 Outlook Webinar: Key Catalysts and their Impact on Pharma Markets

    02 Jul 2019

    Find out which market-moving events and catalysts to watch for during the Q1 Outlook Webinar - Key catalysts and their impact on pharma markets.

    Topic drug-approval drug-development-landscape drug-review

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker: Catalyst Roundup 2018 Q4

    02 Jul 2019

    A Review of Select Catalysts from Last Quarter’s Outlook Report.

    Topic clinical-trials drug-approval drug-review drug-development-landscape

  • Meddevicetracker: 医療機器の市場調査分析・データベース, Biomedtracker: 開発中医薬品を...

    Q2 2019 Outlook Report

    03 May 2019

    In this report, we cover catalysts from 25 drugs, devices and diagnostics expected to occur in Q2 2019. For each drug, the likelihood of Phase/PDUFA review success and overall Likelihood of Approval (LOA) given their particular phase, drug class, and disease group are provided.

    Topic drug-approval drug-development-landscape drug-review

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Datamonitor Healthcare: 医療...

    December 2018 National Influenza Week

    10 Apr 2019

    3 – 9 December is National Influenza Vaccination Week, a national awareness week focused on highlighting the importance of influenza vaccination. In this free KOL Insight Interview excerpt from Datamonitor Healthcare, read what key opinion leaders from the UK and US in Infectious Diseases have to say about current efforts to combat influenza with seasonal influenza vaccines:

    Topic influenza-virus infectious-diseases

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker 2018 Early Outlook Report

    10 Apr 2019

    What's on the horizon for pharma in 2018? Find out with Biomedtracker's Early 2018 Outlook Report extract. Download free extracts from this essential report, which investigates the catalysts expected to occur in the first part of the year for 21 different drugs.

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価, Meddevicetracker: 医療機器の市場調...

    Biomedtracker: Early 2019 Outlook Report Extract

    10 Apr 2019

    In this report, we cover catalysts from 23 drugs, devices and diagnostics expected to occur in early 2019.

    Topic drug-approval drug-review medtech

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets

    19 Nov 2018

    Understand important upcoming milestones that will impact the likelihood of drug approval or future sales potential for key therapies during a free webinar from Informa Pharma Intelligence, "Q4 Outlook Webinar - Key Catalysts and their Impact on Pharma Markets".

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Biomedtracker Q4 2018 Outlook Report

    19 Oct 2018

    Find out what’s in store for the remainder of 2018 with your copy of the Biomedtracker Q4 2018 Outlook Report Extract. This essential analysis of expected Q4 catalysts for 27 drugs is now available to you – for free. Drawn from the full report of the same name, this vital resource explores the likelihood of phase/PDUFA review success and overall Likelihood of Approval (LOA) based on a drug’s phase, drug class, and disease group.

    Topic drug-development-landscape

  • Biomedtracker: 開発中医薬品をFDA承認確率で評価

    Pharma Partnering Trends Revealed Whitepaper

    12 Oct 2018

    Make the most of BIO-Europe 2018 with essential partnering information from Informa Pharma Intelligence. Our insightful whitepaper, Pharma Partnering Trends Revealed: 2018 Edition, contains critical information on the landscape for biotech partnerships, and is now available for you to download – free.

  • Biomedtracker

    Biomedtracker Q3 2018 Outlook Infographic

    22 Aug 2018

    For a look at the outcomes for predicted Q2 2018 catalysts, we invite you to download a free copy of the data-rich Catalyst Roundup infographic from Biomedtracker. This informative graphic takes a look at the outcomes for two major catalysts featured in Biomedtracker’s insightful Q2 2018 Outlook Report.

    Topic drug-development-landscape

  • Biomedtracker

    Biomedtracker Q3 2018 Outlook Report Extract

    15 Aug 2018

    Download an extract of the data-rich resource: Biomedtracker’s Q3 2018 Outlook Report. This latest installment in Biomedtracker’s ongoing quarterly reports contains expected drug catalyst predictions, important clinical and regulatory milestones, and Large Impact catalysts for the upcoming quarter. 

    Topic drug-development-landscape

  • Scrip: 世界の医療用医薬品&製薬産業に関するニュース, Biomedtracker: 開発中医薬品をFDA承認確率...

    ASCO Essentials Webinar 2018 Recording

    29 May 2018

    Just in time for your 2018 ASCO Annual Meeting planning, join analysts from Datamonitor Healthcare, Biomedtracker, Citeline, Scrip, and Pink Sheet for their expert opinions on what you need to know to get the most from the meeting. Let our experts present their top picks from the thousands of abstracts being presented at ASCO.

    Topic clinical-trials

医薬品産業専門のジャーナリスト&アナリスト

Management

Richard Faint

Management, Head of Medtech
Richard Faint

Richard specializes in

  • Biopharma pipeline strategy
  • Biotech
  • Commercial Strategy
  • Diagnostics
  • Dietary Supplements

+26 year(s) experience

Analyst

Chrystal Larsen

Analyst, Lead Market Analyst
Chrystal Larsen

Chrystal specializes in

  • Medical Devices
  • Medtech
  • Metabolic
  • Neurology
  • Market Intelligence

+24 year(s) experience

Management

Gail Parziale

Management, ​Head of Intelligence Editorial Operations
Gail Parziale

Gail specializes in

  • Commercial Strategy
  • Clinical Trials

+22 year(s) experience

製品説明を兼ねた無料デモ&お問い合わせ

専任スタッフによる詳しい説明を兼ねた無料デモンストレーションを常時受け付けています。ご希望の場合は下記のフォームよりお気軽にお申し込みください。

ご質問等ございましたらお気軽にご連絡下さい。

日本(平日:9時~18時)
電話:+81 (0)3 6273 4260
Email:inquiry.jp@informa.com

オンラインショップのレポートストアでは、医療用医薬品の市場調査・分析レポートを常時1000本以上販売しています。レポート1本単位で購入でき、オンラインでご提供いたします。

お探しの情報が見つからない場合はお問い合わせ先までお気軽にご連絡ください。